Molecular cloning and functional analysis of a novel oncogene, cancer-upregulated gene 2 (CUG2)
- Department of Microbiology, Chungnam National University, Daejeon 305-764 (Korea, Republic of)
- Department of Internal Medicine, Brain Korea 21 Project for Medical Science, Yonsei University College of Medicine, Seoul (Korea, Republic of)
- LG Life Sciences, Ltd./R and D Park, Daejeon (Korea, Republic of)
- Korea Research Institute of Bioscience and Biotechnology, Daejeon 305-333 (Korea, Republic of)
We examined genome-wide differences in gene expression between tumor biopsies and normal tissues in order to identify differentially regulated genes in tumors. Cancer-upregulated gene 2 (CUG2) was identified as an expressed sequence tag (EST) that exhibits significant differential expression in multiple human cancer types. CUG2 showed weak sequence homology with the down-regulator of transcription 1 (DR1) gene, a human transcription repressor. We found that EGFP-CUG2 fusion proteins were predominantly localized in the nucleus, suggesting their putative role in gene regulation. In addition, CUG2-overexpressing mouse fibroblast cells exhibited distinct cancer-specific phenotypes in vitro and developed into tumors in nude mice. Taken together, these findings suggest that CUG2 is a novel tumor-associated gene that is commonly activated in various human cancers and exhibits high transforming activities; it possibly belongs to a transcription regulator family that is involved in tumor biogenesis.
- OSTI ID:
- 20991513
- Journal Information:
- Biochemical and Biophysical Research Communications, Vol. 360, Issue 3; Other Information: DOI: 10.1016/j.bbrc.2007.06.102; PII: S0006-291X(07)01345-9; Copyright (c) 2007 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved; Country of input: International Atomic Energy Agency (IAEA); ISSN 0006-291X
- Country of Publication:
- United States
- Language:
- English
Similar Records
MicroRNA-373 functions as an oncogene and targets YOD1 gene in cervical cancer
MiR-141-3p is upregulated in esophageal squamous cell carcinoma and targets pleckstrin homology domain leucine-rich repeat protein phosphatase-2, a negative regulator of the PI3K/AKT pathway